@NPRA1985 I'll say this again. If anyone wants to enter better enter now. Dont regret once if flies.

I think it has entered its momentum phase - now trading above 20MA should take it towards next resistance at 0.255

For one lot of Bintai (whose vaccine progress is not known), you can buy 4 lots of Kanger (which Sinopharm is in its final stages of trial).

0.19 is a good EP because that would have given it enough momentum to scale new heights - with next resistance level at 0.255

Looks like it is moving slowly like Bintai Kinden in the early days of 0.28 and below. Then it just flew from Aug 13 onwards. The difference is that Sinopharm is almost done trial-testing while Bintai is still groping for a vaccine. This looks like it

Good for Kanger - looks like this is the one vaccine-related counter to move now

Not surprising if it closes back to 0.675 judging from the selling points from 0.70

You buy one rumours? That is one way of going to hell.

@JXnotJAX bow that's first value, 2nd value @ 1.18?
28/10/2020 2:29 PM

i don't buy for immediate gains. Whether it is 0.80 or 1.18 don't matter. Long term investment until fundamental prove otherwise.

Vsolar is being played by the big boys. If you don't have at least 100k units, just leave it there until Kingdom Come. If it rises, it rises. Otherwise there is no reason why people should push the stock to new levels of high. As it is, there is no substantial news for this company. Previously, at least the share base is not so huge. Now, it will take days to mop up panic selling. Even if there is good economic data, at most, it will go up to another 5 sen. Not more, very likely

Recent developments in Sabah and elsewhere is driving demand for increased bed capacity and other medical peripherals LKL is producing. Might one guess that the coming quarter will be a profitable one also, given spending have been relegated to the last.

This below will also factor into the anticipated profitability as it is supplying nitrile gloves as well

http://lkl.irplc.com/medianews.htm?filepath=LKL/LKL-TheEdgeMarkets-14092020.pdf

The downtrend is ending from the looks of the direction it is taking on the charts.

@Asyraf96 Buy bintai nows for pullback


What pullback. Look at Generex share prices and see if it is going anywhere

Locked in retailers are selling off. Look at volume, if small, then it is only these selling out because of several reasons - lack of funds, margin calls, or simply unsure of their investment. Right now, volume is only 2mil. At RM1.02, it is steal

Interesting:
https://codeblue.galencentre.org/2020/10/05/fitch-raises-political-ties-in-covid-vaccine-deals-including-malaysian-bamboo-company/


"Sinopharm had initiated their Phase Three clinical trial for the Covid-19 vaccine on July 17, which puts it on a similar timeline to candidates in development from Moderna and Pfizer, which both entered their Phase Three studies on July 27.

Sinopharm chairman Liu Jingzhen reportedly said in August that he expects Sinopharm’s vaccine to be in the market by December 2020.

According to Fitch Solutions, data from Phase One/Two trials of Sinopharm’s coronavirus candidate vaccine showed that it was able to stimulate a robust immune system with only limited safety concerns. Adverse effects seen were low-grade symptoms, such as fever and pain at the injection site, with no other serious adverse effects."

Just be careful with hardearned money. Time like this is not for gambling - check until you are confident with the findings, then invest. A single stock trader is no match for funds that work in tandem. Has Pos fundamentals improved since last year? Results matter. Check, check and check.

Look at KWAP disposal since July will tell you lots

https://malaysiastock.biz/Company-Announcement.aspx?id=1263742

@
butterflyfly will it one day show?

Look at the chart from Oct 9. Prelude to this? Will others get caught again?

@
cherry88 Will Matrix also involve in healthcare in a big way ? then it will limit up like Mah Sing.
19/10/2020 4:53 PM

Actually it has, it is also involved in education. As for its reputation being very bad - that remains to be seen.

Watch the trend of selling. A real master at work.

Gone with the wind if you purchased this

Goreng down now. Scalping in progress. Same trend happened between 8 and 13 Oct ending in new lows. See profit, take profit. Dont be greedy and get caught

@MCDIDDY HWGB IS THE REAL KING. FORGET ABOUT SOLUTN AND BINTAI.
19/10/2020 11:03 AM

Yes, but you forgot Kanger

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30831-8/fulltext

This is the latest from The Lancet. Can anyone verify if the study conducted was under the same organisation which Kanger was earlier reported to have collaboration with in the story below?

https://www.theedgemarkets.com/article/kanger-collaborate-sinopharm-distribution-covid19-vaccine%C2%A0 - Sept 29 story

I think China will see its wish of producing vaccine for the good of humanity come true. This will be its present to the US that has been continually critical of it for the virus. If China vaccine proves without side effects and can alleviate some of the Covid 19 symptoms, then it could bring enough goodwill that may translate into other trade benefits

If HWGB breaks 79sen next week, it will be comfortable in its retracement upwards - which means at its high of 1.36 on August 25. The rise in potential will depend on how fast its other vaccine venture is coming along. From what is know, the company is quite active in making alliances at strategic places, so you can rest assured that at least the company is responding to what investors are looking for or interested in. If you study Bintai, this stock is at least pursuing aggressively its end product. So that you roughly know what you are buying into

HWGB's partner is listed on the Shenzhen Stock Exchange under CNI Biomedicine I think. Look up its stock and see that it has grown over 24% since last five months and still climbing. Congrats all who are on this wagon.

@
malysiabolehhh http://hwgbbiotech.com/news/view_news.php?news_id=84

Now this turns the tide. While Bintai Kinden has practically nothing to show, HWGB has already one in the bag. Its venture with Wuhan Easydiagnosis Biomedicine Co Ltd with the test kits which has met MOH approvals means it can distribute it here - and overseas in neighbouring countries using that testimonial as backing. If its venture bears fruit, we are looking at a runaway locomotive. Prior, we are still talking about heresay. This is news. Buy on news, they say?

Yesterday Appasia broke the psychological resistance of 0.575. Strong fund support pushed it to today's level, and I believe momentum is strong enough to crack at 0.675 next. Once this is broken, it will scale new heights befitting its expected results for the next quarter

Malaysia just joined Covac. Looks like when vaccine is ready, only one of two Government appointed firms will benefit. Unless those purported vaccine manufacturers that have joined venture with our local companies can really produce a viable vaccine. If not, a lot of investors will be caught. So, if you are investing in vaccine counters per see, please keep a sharp eye on all the details if you have a lot running. If not, slow sell may see a huge wipe-out of what you put in.

@JXnotJAX don't worry, will slowly up, this not goreng counter

Only those who are caught buying via rumours and had to sell are becoming sour. If you know what you are investing, then there is little worry. Only when you are unsure and do not have a strong foundation will your feet sway even at the slightest fart sound

Yes, but take this statement as a caution. We are investing, not throwing salt into sea.

"We are following closely on the developments in this CRUCIAL venture of our healthcare business as we want to do our bit in helping to combat the virus that has affected the health of so many, including their livelihoods and income,” Dato’ Aaron Lim said."

Meaning if it doesn't get through, HWGB is in deep sea. Just follow developments closely. There are currently 162 possible candidates in different stages of trials. Only the Chinese claim that theirs are at the final stages and already on thousands of human trials.US based ones are more stringent . Eli Lilly just halted testing because of one unexplained health issue of one of its respondents. As a result, EL shares were dropped cold.

No politician will admit owning any public company, let's face it. But when it comes to an election, one wonders where money will come from - certainly not well-wishers who just throw cash into the coffers without looking for goodwill.

Anyone know how this vaccine is going to be like or is there any information? How will it be distributed and who will have final say in the distribution? In vaccine investment - it is a 50-50 thing. This counter is better than Bintai in the sense that it has inked many JVs with companies in the study and making of vaccines. But there is a ceiling price for all stocks for all it's worth. Continuously chasing its high will end up being caught by smartmoney who has better and faster data than the common people in the streets like you and me who depend on rumours. Those who do more research will benefit and they may share with you their findings - AFTER they already bought into the market. So, watch this stock at its current high price. If you have profited, good. If not, a wait may not be a bad thing. Until someone finds an effective vaccine, any rumour is only as good as coffeeshop talk

Did you realise that PRDM no longer allows you to use MyEg to pay summons? There is one big chunk of business gone. How many will follow? I think this sorts of average out whatever it will be doing

better keep shares - when is exit date

Yes, even Ely Lilly has halted because of safety issues. Generex if it is anywhere near development an effective vaccine would have flown sky high and drag Bintai with it. So far, it is mere speculation that is maintaining the Bintai prices now.

It wont have limit up. This business is also quite competitive. What will happen is probably profit taking. See how much selling there was at 1.15-1.16, I think it may drop back to 1.10 or lower before heading up again. Good news is the company is acquiring premises to increase its production footprint but results will only be seen after the factories are built and possibly show results in two or more quarters

Not good:

https://codeblue.galencentre.org/2020/10/08/malaysian-engineering-company-signs-deal-for-covid-vaccine-with-unknown-clinical-research/

@Avalon88
Thanks for your analysis. Commonsense will also tell us that left hand is selling to right when and when it's done enough, one hand will be removed to that people will chase next level. There is nothing from this company that warrants positivity let alone confidence

Soar up? Heikin Ashi is not foolproof. You need others - even with MACD, it does not show much. Right now, it's just predictable play from 0.035 to 0.04 and back. As long as there is no institutional funds looking at this stock, only retailers will play for shorts and you end up caught most of the time if you are not careful

Check its PE. So far, projected earnings are from the e.Confirm and Yellow Pages. If new projects are announced, then to may shoot higher than the 90sen level previously held. If not wait for third week of Nov when the quarter results are out. This should show positive signs

Those with funds are playing on small fry - they block either way to prevent rise or fall and psychologically force the greedy ones to buy or sell.

@amithaba this gnbt and bintai is trying to make news using social media to goreng their share only...very old tricks.
08/10/2020 3:53 AM

there is a taker every day and so you see those who do not do research end up winning on bet and losing the other nine

As long as there is no concrete news, it will be 62-68sen play, up and down. Who is smart, they don't get caught.

@KLLee_0110 Bintai shouldn’t below RM1.
07/10/2020 9:31 AM

What do you based this assumption on?

Where are the data supporting that a vaccine is already on hand with Generex? All I read are appoints of board members to supervise its development (only now?) and MoUs signed with other companies, including Bintai. GNBT is still very suppressed in price. Until that one flies, be reserved about this stock.

@
Avalon88 https://www.google.com/amp/s/www.nst.com.my/amp/business/2020/06/60445...

Old news. When it went up, after that, price already reflected - then it crashed and burned

There are no good news, what to expect? It will not go up any higher than 7sen.

@
KLLee_0110 If vaccine coming in Bintai will be the first get the pririoty
05/10/2020 10:52 AM

Where did you get this information?

Just heard - Sabah hospitals would need additional beds to house increasing number of patients. This should be good news for LKL.